News Desk:

Tired of Menopause symptoms affecting your daily routine? Call us on 1300 883 405

Aug 13, 2020 Controversy Corner Ron Loftus 240 views

If distinguished Professor Harvey Risch, who is also a critic of big drug companies is correct, then the real reason that Hydroxychloroquine (HCQ) has been pilloried by other experts is that it is easily and cheaply manufactured and thus will not make the big pharmaceutical companies richer.

Professor Risch has written a review article on the topic of HCQ in the American Journal of Epidemiology where he notes that he has evidence that supports the use of the drug for outpatients who have the SARS CoV-2 infection.

Dr Risch is a highly regarded cancer epidemiologist. He has written a review article about HCQ and states that he has evidence for his belief that the drug is effective.

Dr Rich is convinced about the drug’s potential ability to “reduce the risk of hospitalisation and mortality, dramatically, in high risk patients” when used in conjunction with zinc and an antibiotic. A recent article by professor Risch states that the anti-malarial drug HCQ could save thousands of lives.[1]

The President of the USA, Donald Trump was supportive of the use of HCQ and was even taking it himself at one point. He copped much criticism for doing so. Dr Risch alludes to the fact that HCQ is widely produced and is ‘very cheap’ as being why drug companies are not advocating its use. Could it be that the same old story of big pharma calling the shots once again and risking the possible loss of thousands of lives?

On 12th August the Russian President Vladimir Putin[2] announced that the Russian Health Ministry approved of a new vaccine (not HCQ) and stated that one of his two daughters had been inoculated. He announced that the vaccine had been through the necessary testing and was shown to give lasting immunity.

Whilst the normal processes to prove the safety and effectiveness of treatments can take many months if not years, do we have the right to deny people the use of vaccines and treatment that can save their life while we wait for the usual hurdles and money eating monopolies to dictate to all what they can and can’t do?





Ron Loftus

About The Author - Ron Loftus

Ron Loftus is the General Manager of the Australian Menopause Centre and leads the team. He has many years of experience within the medical industry. His detailed and focused approach to every matter ensures our centre maintains high standards in patient care and that we are forever seeking ways of improving our systems and practices.

Sign Up For Our Free Newsletter Today

Get great monthly articles for valuable information to assist with your menopause management

Free No Obligation Medical Consultation